The global neurological disorders drugs market is expected to grow at a significant CAGR during the forecast period. Neurological disorders are characterized by dysfunction in any part of the brain or nervous system, which causes damage or injury. For the treatment of neurological illnesses, a variety of neurological medications such as antipsychotics, antiepileptics, anticholinergics, and analgesics are available on the market.
The growth of neurological disorders drug market is expected to witness due to significant investment in R&D. In September 2020, A team led by Rutgers has developed a smart medicine delivery device that supports cure spinal cord injuries and other neurological illnesses by reducing inflammation in injured neural regions. According to a study published in the journal Advanced Materials, the technology, which uses incredibly thin biomaterials implanted in the body, also protects nerve fibres (axons) that connect nerve cells in wounded brain tissues. Ultrathin nanomaterials, sugar polymers, and neuronal proteins make up the team’s unique medication delivery method. The mechanism, which releases an anti-inflammatory chemical (methylprednisolone), can support promote tissue repair and recovery after a brain injury by creating a favourable microenvironment. As inflammation is linked to a range of disorders such as CVD, osteoarthritis, diabetes, and cancer, the researchers believes the new approach could pave the way for treating not only central nervous system injuries, however, also other ailments.
The key companies operating in the industry are highly inclined towards the adoption of different growth strategies including capacity expansion, partnerships, mergers and acquisitions, geographical expansion, new product launch, FDA Approval and product innovation to remain competitive in the marketplace. For instance, Aduhelm (aducanumab) was approved by the US Food and Drug Administration in June 2021 for the treatment of Alzheimer’s disease, a severe condition that affects 6.2 million Americans. Aduhelm was approved through the accelerated approval pathway, which is reserved for drugs that give a significant therapeutic advantage over existing treatments for serious or life-threatening illnesses. With a mandatory post-approval trial to verify that the medicine achieves the projected clinical benefit, accelerated approval can be based on the drug’s effect on a surrogate endpoint that is fairly likely to predict a therapeutic benefit to patients.
To Request a Sample of our Report on Neurological Disorders Drugs Market: https://www.omrglobal.com/request-sample/neurological-disorders-drugs-market
Market Coverage
- The market number available for – 2022-2030
- Base year- 2022
- Forecast period- 2023-2030
Segment Covered-
- By Disease
- By Distribution Channel
Regions covered-
- North America
- Europe
- Asia-Pacific
- Rest of the World
Competitive Landscape: Pfizer Inc., Teva Pharmaceutical Industries Ltd., and Sanofi S.A., among others.
Neurological Disorders Market Report by Segment
By Disease
- Epilepsy
- Parkinson’s disease
- Alzheimer’s disease
- Others
By Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
A full Report of Neurological Disorders Drugs Market is Available @ https://www.omrglobal.com/industry-reports/neurological-disorders-drugs-market
Neurological Disorders Market Report by Region
North America
- United States
- Canada
Europe
- UK
- Germany
- Spain
- France
- Italy
- Rest of Europe
Asia-Pacific
- India
- China
- Japan
- South Korea
- Rest of APAC
Rest of the World
- Latin America
- Middle East & Africa
Reasons to buy from us –
- We cover more than 15 major industries, further segmented into more than 90 sectors.
- More than 120 countries are for analysis.
- Over 100+ paid data sources mined for investigation.
- Our expert research analysts answer all your questions before and after purchasing your report.
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services. The company also offer Digital Marketing services through its subsidiary OMR Digital and Software development and Consulting Services through another subsidiary Encanto Technologies.
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 7803040404
